Virtue Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,354
| Closed | -$929K | – | 367 |
|
|
2023
Q3 | $929K | Hold |
14,354
| – | – | 0.16% | 120 |
|
|
2023
Q2 | $929K | Buy |
14,354
+1,969
| +16% | +$127K | 0.16% | 120 |
|
|
2023
Q1 | $842K | Sell |
12,385
-10,982
| -47% | -$747K | 0.14% | 128 |
|
|
2022
Q4 | $1.68M | Buy |
23,367
+17,630
| +307% | +$1.27M | 0.26% | 59 |
|
|
2022
Q3 | $408K | Sell |
5,737
-1,830
| -24% | -$130K | 0.06% | 134 |
|
|
2022
Q2 | $583K | Sell |
7,567
-5,015
| -40% | -$386K | 0.09% | 100 |
|
|
2022
Q1 | $919K | Buy |
12,582
+477
| +4% | +$34.8K | 0.14% | 179 |
|
|
2021
Q4 | $755K | Sell |
12,105
-336
| -3% | -$21K | 0.11% | 212 |
|
|
2021
Q3 | $736K | Buy |
12,441
+3,439
| +38% | +$203K | 0.13% | 203 |
|
|
2021
Q2 | $601K | Sell |
9,002
-601
| -6% | -$40.1K | 0.12% | 208 |
|
|
2021
Q1 | $606K | Sell |
9,603
-293
| -3% | -$18.5K | 0.14% | 184 |
|
|
2020
Q4 | $614K | Sell |
9,896
-29,742
| -75% | -$1.85M | 0.15% | 180 |
|
|
2020
Q3 | $2.39M | Sell |
39,638
-1,212
| -3% | -$73.1K | 0.59% | 39 |
|
|
2020
Q2 | $2.4M | Buy |
+40,850
| New | +$2.4M | 0.55% | 48 |
|
|
2019
Q3 | – | Sell |
-15,684
| Closed | -$711K | – | 227 |
|
|
2019
Q2 | $711K | Buy |
+15,684
| New | +$711K | 0.26% | 108 |
|
|
2018
Q4 | – | Sell |
-16,378
| Closed | -$1.02M | – | 109 |
|
|
2018
Q3 | $1.02M | Buy |
16,378
+10,309
| +170% | +$640K | 0.21% | 117 |
|
|
2018
Q2 | $336K | Buy |
6,069
+2,688
| +80% | +$149K | 0.16% | 164 |
|
|
2018
Q1 | $172K | Buy |
3,381
+2,086
| +161% | +$106K | 0.09% | 199 |
|
|
2017
Q4 | $79K | Buy |
+1,295
| New | +$79K | 0.04% | 243 |
|